‘Experimental Ebola Vaccine’ To Be Used On Poor African Village

Ebola is back. With Zika all but a distant memory, Ebola is now quickly seeping back into the mainstream news cycles.

The most recent news involves the World Health Organization fighting an outbreak in Democratic Republic of Congo. As it stands, 39 people have reportedly been diagnosed with Ebola. The WHO says that between 20 and 90 percent of those people will die. The huge margins for fatalities as they relate to Ebola is, well, odd.

“We are very concerned and we are planning for all scenarios, including the worst-case scenario,” said Dr. Peter Salama, WHO’s deputy director general for emergency preparedness and response, per NBC News.

In order to achieve readiness, the WHO has announced it will use an experimental Ebola vaccine. The descriptor, “experimental,” was actually used.

The 2014-2016 Ebola epidemic ended up killing upwards of 11,000 people. Additionally, mainstream media in the United States worked hard to “make Ebola happen” here, also (but it never did happen).

The current Ebola cases are housed in remote parts of the region, however, the WHO is fearing that won’t be the case for long.

“Even though it’s a remote, rural area, which usually gives us a sense of reassurance in the sense of an outbreak, the problem is that we already have three separate locations that are reported cases that cover as much as 60 km (37 miles) or more,” Salama told a news conference.

The WHO is also blaming the use of “faith healers” and poor burial methods for the spread of Ebola in many of these areas. Most of the infected areas have no proper roads to use for getting in or out of the region.

Photo by Army Medicine

Support Vaxxter

Your Donation Helps Us Fight Censorship And Remain Ad-Free

[give_form id="5471"] If you prefer snail mail instead, make donation checks payable to CHOONADI, LLC, owner of Vaxxter.com 7380 Engle Road Middleburgh Hgts, OH 44130

Be the first to comment on "‘Experimental Ebola Vaccine’ To Be Used On Poor African Village"

Leave a comment

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.